Publication Date:
2015-08-14
Description:
Article Increased fibronectin expression is associated with high-risk breast cancer and metastasis. Here, the authors develop a penta-peptide CREKA-targeted MRI contrast agent that binds to fibronectin and show its potential for early detection of breast cancer and micrometastasis. Nature Communications doi: 10.1038/ncomms8984 Authors: Zhuxian Zhou, Mohammed Qutaish, Zheng Han, Rebecca M. Schur, Yiqiao Liu, David L. Wilson, Zheng-Rong Lu
Electronic ISSN:
2041-1723
Topics:
Biology
,
Chemistry and Pharmacology
,
Natural Sciences in General
,
Physics
Permalink